Code of Life Via AI

Abstract

Artificial intelligence (AI) is rapidly reshaping modern medicine, especially with the growing availability of digital health records, powerful computing systems, and large-scale genomic data. In clinical settings, AI tools now support diagnostic decision-making, help manage electronic health records, and even guide robotic systems used in surgery and patient care. In genomics, AI has become particularly valuable for interpreting the massive datasets produced by next-generation sequencing. These approaches help identify structural variants, analyze non-coding mutations, and integrate information from multiple omics layers to better understand disease mechanisms. Machine-learning algorithms are also improving the accuracy of read alignment, variant calling, and prediction of how specific genetic changes influence disease. AI has shown impressive success in fields like oncology and medical imaging, often matching or surpassing expert-level performance. It is also accelerating biomarker discovery by allowing researchers to study genome, proteome, and metabolome data at the same time, rather than relying on traditional single-marker methods. In neurodevelopmental disorders, AI has helped analyze complex sequencing datasets and improved interpretation of genetic variants linked to conditions such as autism and epilepsy. Despite its potential, the use of AI in genomics faces important challenges. These include the need for high-quality data, difficulties in interpreting complex model outputs, ethical concerns around privacy, risks of algorithmic bias, and the high computational resources required. While AI offers significant opportunities to advance precision medicine, its best use will come from combining powerful computational tools with skilled human expertise to ensure accuracy, fairness, and responsible clinical application.